GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling

Koch, Corinna; Samareh, Bardia; Morishima, Tatsuya; Mir, Perihan; Kanz, Lothar; Zeidler, Cornelia; Skokowa, Julia; Welte, Karl

dc.contributor.author	Samareh, Bardia
dc.contributor.author	Morishima, Tatsuya
dc.contributor.author	Mir, Perihan
dc.contributor.author	Kanz, Lothar
dc.contributor.author	Skokowa, Julia
dc.contributor.author	Welte, Karl
dc.date.accessioned	2018-02-16T14:45:53Z
dc.date.available	2018-02-16T14:45:53Z
dc.date.issued	2017
dc.identifier.issn	1432-0584
dc.identifier.uri	http://hdl.handle.net/10900/80582
dc.language.iso	en	de_DE
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s00277-016-2894-5	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_01682
utue.publikation.seiten	345-353	de_DE
utue.personen.roh	Koch, Corinna
utue.personen.roh	Samareh, Bardia
utue.personen.roh	Morishima, Tatsuya
utue.personen.roh	Mir, Perihan
utue.personen.roh	Kanz, Lothar
utue.personen.roh	Zeidler, Cornelia
utue.personen.roh	Skokowa, Julia
utue.personen.roh	Welte, Karl
dcterms.isPartOf.ZSTitelID	Annals of Hematology	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	96	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE